glp-1 receptor agonists for type 2 diabetes GLP1 vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Trends in the Development of

Nishita Pattni, senior consultant at Worldpanel by Numerator, said: "Rising adoption in markets like the US, combined with continued innovation, points to even faster uptake

Vos T, Lim SS, Abbafati C et al

The system for challenging patents created by the Hatch-Waxman Act does not appear to function well for drug-device combinations

For many GLP-1 users, starting with foundational nutrition support and adjusting gradually based on personal needs is a more sustainable approach

Cechin S, Perez-Alvarez I, Fenjves E, et al

The availability of semaglutide in different formulations, such as injections and oral tablets, provides patients with options that cater to their preferences